{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:14:33Z","timestamp":1760426073506},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Women and Childrens Health Research Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sickle cell disease is an inherited chronic hematological disorder with an average lifespan of fifty years. The human cost of sickle cell disease includes missed school days, occupational opportunities, social isolation, stigmatization, and psychological sequelae. Hematopoietic cell transplantation (HCT) is the only curative therapy available but comes with potential morbidity and mortality. Our study explores how quality of life (QoL) is affected from the perspective of an adolescent who has undergone a nonmyeloablative matched sibling donor HCT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We employed multiple case study methodology with purposeful sampling by selecting information-rich cases. Data sources: 1) QoL inventories 2) patient interviews 3) parent interview 4) vital support interview 5) medical record analysis. Data analysis: Intra-case analysis by assembling evidence within a single case and then analyzing the differences within cases to create a rich case description. Next, a time series analysis was completed to track changes in patients\u2019 QoL. We used multiple sources of data to compose a timeline and changes across time. Then, we employed pattern matching as an analytical technique allowing for examination of patterns across cases. Finally, we used cross case synthesis to review results of each case.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Quality of life was reported across the physical, social and psychological domains for 5 participants. All had sickle cell HgSS genotype, 80% were male and 80% were born outside of Canada. Physical domain: pre-transplant, 100% of patients experienced pain, and the majority suffered from fatigue, insomnia, and fevers resulting in hospitalizations. Afterwards, participants reported improved physical wellbeing. Social domain: pre-transplant, QoL was poor characterized by stigma, social isolation, and parental absenteeism. Post-HSCT adolescents gained social acceptance in areas that had stigmatized and excluded them. They were able to participate freely in activities with peers and their social life vastly improved. Psychological pre-transplant life experiences were overshadowed by psychological stress. The majority commented that their future was bleak and may lead to premature death. Afterwards adolescents described a crisis free life with positive psychological outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Adolescents with sickle cell disease who undertook HCT demonstrated improved QoL one year post transplant with regard to physical, social and psychological well-being.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-022-02021-w","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T09:02:52Z","timestamp":1659171772000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ADaPTS \u201c(AD)olescents (P)ath through (T)ransplant (S)ickle cell disease\u201d"],"prefix":"10.1186","volume":"20","author":[{"given":"Aisha A. K.","family":"Bruce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M. T.","family":"Guilcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony H.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Leaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic A.","family":"Alaazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasia J. V.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bukola","family":"Salami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"2021_CR1","unstructured":"Organization WH. Genomic resource centre. 2016; http:\/\/www.who.int\/genomics\/public\/geneticdiseases\/en\/index2.html"},{"issue":"1","key":"2021_CR2","first-page":"25","volume":"37","author":"AKBS Hildenbrand","year":"2015","unstructured":"Hildenbrand AKBS, Barakat LPP, Alderfer MAP, Marsac MLP. Coping and coping assistance among children with sickle cell disease and their parents. J Ped Hem\/Onc. 2015;37(1):25\u201334.","journal-title":"J Ped Hem\/Onc"},{"issue":"11","key":"2021_CR3","first-page":"752","volume":"29","author":"LPP Barakat","year":"2007","unstructured":"Barakat LPP, Patterson CAP, Weinberger BSMS, Simon KMS, Gonzalez ERMS, Dampier CMD. A prospective study of the role of coping and family functioning in health outcomes for adolescents with sickle cell disease. J Ped Hem\/Onc. 2007;29(11):752\u201360.","journal-title":"J Ped Hem\/Onc"},{"issue":"2","key":"2021_CR4","first-page":"128","volume":"37","author":"LMMSP Beverung","year":"2015","unstructured":"Beverung LMMSP, Varni JWP, Panepinto JAMDM. Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease. J Ped Hem\/Onc. 2015;37(2):128\u201333.","journal-title":"J Ped Hem\/Onc"},{"issue":"7\u20138","key":"2021_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/08880018.2018.1541949","volume":"35","author":"AAK Bruce","year":"2018","unstructured":"Bruce AAK, Witol A, Alvadj-Korenic T, Mayan M, Greenslade H, Plaha M, et al. A complex interface: exploring sickle cell disease from a parent\u2019s perspective, after moving from Sub-Saharan Africa to North America. Ped Hem and Onc. 2018;35(7\u20138):373\u201384. https:\/\/doi.org\/10.1080\/08880018.2018.1541949.","journal-title":"Ped Hem and Onc"},{"issue":"8","key":"2021_CR6","first-page":"595","volume":"37","author":"CMD Corriveau-Bourque","year":"2015","unstructured":"Corriveau-Bourque CMD, Bruce AAK. The changing epidemiology of pediatric hemoglobinopathy patients in northern Alberta, Canada. J Ped Hem\/Onc. 2015;37(8):595\u20139.","journal-title":"J Ped Hem\/Onc"},{"issue":"6","key":"2021_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.21408","volume":"84","author":"TL Kauf","year":"2009","unstructured":"Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hem. 2009;84(6):323\u20137.","journal-title":"Am J Hem"},{"issue":"5","key":"2021_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2040620713483063","volume":"4","author":"S Shenoy","year":"2013","unstructured":"Shenoy S. Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions. Ther Adv Hem. 2013;4(5):335\u201344.","journal-title":"Ther Adv Hem"},{"issue":"12","key":"2021_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ajh.24183","volume":"90","author":"AA King","year":"2015","unstructured":"King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, et al. Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. Am J Hem. 2015;90(12):1093\u20138.","journal-title":"Am J Hem"},{"issue":"24","key":"2021_CR10","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","volume":"361","author":"MM Hsieh","year":"2009","unstructured":"Hsieh MM, Kang EM, Fitzhugh CD, Link B, Bolan CD, Kurlander R, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. NEJM. 2009;361(24):2309\u201317.","journal-title":"NEJM"},{"issue":"3","key":"2021_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bbmt.2015.08.036","volume":"22","author":"SL Saraf","year":"2016","unstructured":"Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, Quigley JG, Khan I, Molokie RE, Hsu LL, Mahmud N, Levinson DJ, Pickard AS, Garcia JG, Gordeuk VR, Rondelli D. Nonmyeloablative stem cell transplantation with alemtuzumab\/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease. Biol Blood Marrow Transplant. 2016;22(3):441\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2015.08.036.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2021_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.bbmt.2019.02.011","volume":"25","author":"GMT Guilcher","year":"2019","unstructured":"Guilcher GMT, Monagel DA, Nettel-Aguirre A, Truong TH, Desai SJ, Bruce A, et al. Nonmyeloablative matched sibling donor hematopoietic cell transplantation in children and adolescents with sickle cell disease. Biol Blood Marrow Transpl. 2019;25(6):1179\u201386. https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.011.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"2021_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbmt.2014.12.007","volume":"21","author":"M Bhatia","year":"2015","unstructured":"Bhatia M, Kolva E, Cimini L, Jin Z, Satwani P, Savone M, et al. Health-related QoL after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Biol Blood Marrow Transpl. 2015;21(4):666\u201372.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2021_CR14","unstructured":"WHOQOL Measuring quality of life. Division of mental health and prevention of substance abuse world health organization. World Health Organization 1997. https:\/\/www.who.int\/mental_health\/media\/68.pdf"},{"key":"2021_CR15","unstructured":"J. M. Semistructured Interview: SAGE Publications, Inc; 2004"},{"key":"2021_CR16","volume-title":"Case study research: design and methods","author":"RK Yin","year":"2009","unstructured":"Yin RK. Case study research: design and methods. Thousand Oaks, CA: Sage Publications; 2009."},{"key":"2021_CR17","unstructured":"Varni JW. The peds QLTM measurement model for the pediatric quality of life inventory. http:\/\/www.pedsql.org\/"},{"key":"2021_CR18","volume-title":"Case study research: design and methods","author":"R Yin","year":"1984","unstructured":"Yin R. Case study research: design and methods. Beverly Hills, CA: Sage Publishers; 1984."},{"issue":"4","key":"2021_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbmt.2017.01.009","volume":"23","author":"S Shenoy","year":"2017","unstructured":"Shenoy S, Angelucci E, Arnold SD, Baker KS, Bhatia M, Bresters D, et al. Current results and future research priorities in late effects after hematopoietic stem cell transplantation for children with sickle cell disease and thalassemia: a consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2017;23(4):552\u201361.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2021_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/bjh.12737","volume":"165","author":"L Dedeken","year":"2014","unstructured":"Dedeken L, L\u00ea PQ, Azzi N, Brachet C, Heijmans C, Huybrechts S, et al. Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Brit J Haem. 2014;165(3):402\u20138.","journal-title":"Brit J Haem"},{"issue":"7","key":"2021_CR21","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","volume":"110","author":"F Bernaudin","year":"2007","unstructured":"Bernaudin F, Socie G, Kuentz M, Chevre S, Duval M, Bertrand Y, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110(7):2749\u201356.","journal-title":"Blood"},{"issue":"5","key":"2021_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06592.x","volume":"137","author":"JA Panepinto","year":"2007","unstructured":"Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale R, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Brit J Haem. 2007;137(5):479\u201385.","journal-title":"Brit J Haem"},{"issue":"11","key":"2021_CR23","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research. Blood. 2017;129(11):1548\u201356. https:\/\/doi.org\/10.1182\/blood-2016-10-745711.","journal-title":"Blood"},{"issue":"5","key":"2021_CR24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbmt.2013.02.010","volume":"19","author":"MH Dallas","year":"2013","unstructured":"Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, et al. Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transpl. 2013;19(5):820\u201330.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2021_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.seminhematol.2018.04.011","volume":"55","author":"GMT Guilcher","year":"2018","unstructured":"Guilcher GMT, Truong TH, Saraf SL, Joseph JJ, Rondelli D, Hsieh MM. Curative therapies: allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease. Semin Hematol. 2018;55(2):87\u201393. https:\/\/doi.org\/10.1053\/j.seminhematol.2018.04.011.","journal-title":"Semin Hematol"},{"issue":"4","key":"2021_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/pbc.24036","volume":"59","author":"MJ Kelly","year":"2012","unstructured":"Kelly MJ, Pennarola BW, Rodday AM, Parsons SK. Health-related QoL (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HCT). Ped Blood Cancer. 2012;59(4):725\u201331.","journal-title":"Ped Blood Cancer"},{"issue":"4","key":"2021_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.bmt.1702527","volume":"26","author":"M Barrera","year":"2000","unstructured":"Barrera M, Pringle LB, Sumbler K, Saunders F. QoL and behavioral adjustment after pediatric bone marrow transplantation. Bone Marrow Transpl. 2000;26(4):427\u201335.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2021_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1182\/bloodadvances.2020002948","volume":"5","author":"SM Badawy","year":"2021","unstructured":"Badawy SM, Beg U, Liem RI, Chaudhury S, Thompson AA. A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy. Blood Adv. 2021;5(2):570\u201383. https:\/\/doi.org\/10.1182\/bloodadvances.2020002948.","journal-title":"Blood Adv."},{"issue":"6","key":"2021_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1182\/blood-2013-03-489112","volume":"122","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013;122(6):1072\u20138. https:\/\/doi.org\/10.1182\/blood-2013-03-489112.","journal-title":"Blood"},{"issue":"1","key":"2021_CR30","first-page":"92","volume":"66","author":"KN DuHamel","year":"2004","unstructured":"DuHamel KN, Manne S, Nereo N, Ostroff J, Martini R, Parsons S, et al. Cognitive processing among mothers of children undergoing bone marrow\/stem cell transplantation. Psychosom Med. 2004;66(1):92\u2013103.","journal-title":"Psychosom Med"},{"issue":"3","key":"2021_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/jpepsy\/23.3.169","volume":"23","author":"K Vannatta","year":"1998","unstructured":"Vannatta K, Zeller M, Noll RB, Koontz K. Social functioning of children surviving bone marrow transplantation. J Ped Psychol. 1998;23(3):169\u201378.","journal-title":"J Ped Psychol"},{"issue":"3","key":"2021_CR32","doi-asserted-by":"publisher","first-page":"e28861","DOI":"10.1002\/pbc.28861","volume":"68","author":"ER Meier","year":"2021","unstructured":"Meier ER, Abraham AA, Ngwube A, Janson IA, Guilcher GMT, Horan J, et al. Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist\/oncologists\u2019 practice focus: a sickle cell transplant advocacy and research alliance (STAR) study. Pediatr Blood Cancer. 2021;68(3):e28861. https:\/\/doi.org\/10.1002\/pbc.28861.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-022-02021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-022-02021-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-022-02021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T09:07:42Z","timestamp":1659172062000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-022-02021-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1186\/s12955-022-02021-w","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the University of Alberta Research Ethic\u2019s Board. Verbal and written consent was obtained for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I give consent to publish this research study as the primary author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}